| The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease N Perakakis, K Stefanakis, CS Mantzoros Metabolism 111, 154320, 2020 | 131 | 2020 |
| Leptin alters energy intake and fat mass but not energy expenditure in lean subjects P Chrysafi, N Perakakis, OM Farr, K Stefanakis, N Peradze, A Sala-Vila, ... Nature communications 11 (1), 5145, 2020 | 76 | 2020 |
| Elafibranor and liraglutide improve differentially liver health and metabolism in a mouse model of non‐alcoholic steatohepatitis N Perakakis, K Stefanakis, M Feigh, SS Veidal, CS Mantzoros Liver International 41 (8), 1853-1866, 2021 | 34 | 2021 |
| Effect of the glucagon‐like peptide‐1 analogue liraglutide versus placebo treatment on circulating proglucagon‐derived peptides that mediate improvements in body weight … SH Kim, F Abbasi, C Nachmanoff, K Stefanakis, A Kumar, B Kalra, ... Diabetes, Obesity and Metabolism 23 (2), 489-498, 2021 | 20 | 2021 |
| The Selective Peroxisome Proliferator‐Activated Receptor Gamma Modulator CHS‐131 Improves Liver Histopathology and Metabolism in a Mouse Model of Obesity and Nonalcoholic … N Perakakis, A Joshi, N Peradze, K Stefanakis, G Li, M Feigh, SS Veidal, ... Hepatology Communications, 2020 | 17 | 2020 |
| Relative Energy Deficiency in sport (REDs): endocrine manifestations, pathophysiology and treatments AM Angelidi, K Stefanakis, SH Chou, L Valenzuela-Vallejo, K Dipla, ... Endocrine Reviews, bnae011, 2024 | 16 | 2024 |
| Circulating levels of proglucagon‐derived peptides are differentially regulated by the glucagon‐like peptide‐1 agonist liraglutide and the centrally acting naltrexone/bupropion … K Stefanakis, A Kokkinos, G Argyrakopoulou, SK Konstantinidou, S Simati, ... Diabetes, Obesity and Metabolism 25 (9), 2561-2574, 2023 | 10 | 2023 |
| PCSK9 and ANGPTL3 levels correlate with hyperlipidemia in HIV-lipoatrophy, are regulated by fasting and are not affected by leptin administered in physiologic or pharmacologic … E Bouzoni, N Perakakis, MA Connelly, AM Angelidi, E Pilitsi, O Farr, ... Metabolism 134, 155265, 2022 | 10 | 2022 |
| The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: Implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation K Stefanakis, M Kokkorakis, CS Mantzoros Metabolism, 156057, 2024 | 9 | 2024 |
| Circulating levels of all proglucagon-derived peptides are differentially regulated postprandially by obesity status and in response to high-fat meals vs. high-carbohydrate meals K Stefanakis, A Kokkinos, S Simati, G Argyrakopoulou, SK Konstantinidou, ... Clinical Nutrition 42 (8), 1369-1378, 2023 | 9 | 2023 |
| Bariatric surgery, through beneficial effects on underlying mechanisms, improves cardiorenal and liver metabolic risk over an average of ten years of observation: A … A Kokkinos, D Tsilingiris, S Simati, K Stefanakis, AM Angelidi, ... Metabolism 152, 155773, 2024 | 8 | 2024 |
| Longitudinal proteomics of leptin treatment in humans with acute and chronic energy deficiency-induced hypoleptinemia reveal novel, mainly immune-related, pleiotropic effects K Stefanakis, M Samiotaki, V Papaevangelou, L Valenzuela-Vallejo, ... Metabolism 159, 155984, 2024 | 6 | 2024 |
| Recent research advances in metabolism, clinical and experimental C Boutari, M Kokkorakis, K Stefanakis, L Valenzuela-Vallejo, E Axarloglou, ... Metabolism 149, 155722, 2023 | 6 | 2023 |
| Metabolism updates: new directions, techniques, and exciting research that is broadening the horizons C Boutari, E Bouzoni, A Joshi, K Stefanakis, OM Farr, CS Mantzoros Metabolism-Clinical and Experimental 102, 2020 | 6 | 2020 |
| Total and H-specific GDF-15 levels increase in caloric deprivation independently of leptin in humans P Chrysafi, L Valenzuela-Vallejo, K Stefanakis, T Kelesidis, MA Connelly, ... Nature Communications 15 (1), 5190, 2024 | 4 | 2024 |
| Expanding diagnostic and therapeutic horizons for MASH: comparison of the latest and conventional therapeutic approaches G Anastasiou, K Stefanakis, MA Hill, CS Mantzoros Metabolism-Clinical and Experimental 161, 2024 | 2 | 2024 |
| Leptin physiology and pathophysiology in energy homeostasis, immune function, neuroendocrine regulation and bone health K Stefanakis, J Upadhyay, AR Cisneros, N Patel, A Sahai, CS Mantzoros Metabolism, 156056, 2024 | 2 | 2024 |
| Circulating total and H-specific GDF15 levels are elevated in subjects with MASLD but not in hyperlipidemic but otherwise metabolically healthy subjects with obesity C Boutari, K Stefanakis, S Simati, V Guatibonza-García, ... Cardiovascular Diabetology 23 (1), 174, 2024 | 2 | 2024 |
| Total and H‐specific growth/differentiation factor 15 levels are unaffected by liraglutide or naltrexone/bupropion administration SK Konstantinidou, G Argyrakopoulou, S Simati, K Stefanakis, A Kokkinos, ... Diabetes, Obesity and Metabolism, 2024 | 2 | 2024 |
| Long-term clinical outcomes and mediating mechanistic effects of bariatric surgery on adipokines and gastrointestinal hormone secretion: the first 10-year long longitudinal and … A Kokkinos, D Tsilingiris, S Simati, AM Angelidi, K Stefanakis, ... Metabolism-Clinical and Experimental 142, 2023 | 1 | 2023 |
